Abstract
AbstractWhite spot syndrome virus (WSSV) causes severe disease in crustaceans, specifically shrimp, leading to substantial economic losses to the aquaculture industry. Existing treatment methods fail to sufficiently curb the occurrence and spread of the disease, necessitating the development of effective control and treatment strategies. Structural studies have primarily focused on envelope proteins and a few non‐structural proteins involved in host entry, viral replication, viral assembly and host immune evasion, thus presenting themselves as potential drug targets. Here, we provide a comprehensive review of the insights gained from such structural elucidations to contribute to developing novel therapeutic strategies. In addition, we touch upon the current and future perspectives towards structure‐based drug or vaccine development against WSSV.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
